Código QR (código de barras bidimensional)

Targeting Protein Kinase C in Glioblastoma Treatment

Glioblastoma (GBM) is the most frequent and aggressive primary brain tumor and is associated with a poor prognosis. Despite the use of combined treatment approaches, recurrence is almost inevitable and survival longer than 14 or 15 months after diagnosis is low. It is therefore necessary to identify...

תיאור מלא

שמור ב:
Principais autores: Noelia Geribaldi-Doldán, Irati Hervás-Corpión, Ricardo Gómez-Oliva, Samuel Domínguez-García, Félix A. Ruiz, Irene Iglesias-Lozano, Livia Carrascal, Ricardo Pardillo-Díaz, José L. Gil-Salú, Pedro Nunez-Abades, Luis M. Valor, Carmen Castro
פורמט: Artigo
שפה:Inglês
יצא לאור: MDPI AG 2021-04-01
סדרה:Biomedicines
נושאים:
glioblastoma
protein kinase C
glioma stem cells
neurogenesis
neural stem cells
temozolomide
גישה מקוונת:https://www.mdpi.com/2227-9059/9/4/381
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים